These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 421699

  • 1. Effect of flavoxate on hyperactive detrusor muscle.
    Jonas U, Petri E, Kissel J.
    Eur Urol; 1979; 5(2):106-9. PubMed ID: 421699
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Neurogenic disturbances of the bladder treated with flavoxate (Urispadol)].
    Pedersen E, Bjarnason EV, Hansen PH.
    Ugeskr Laeger; 1973 Oct 22; 135(43):2313-7. PubMed ID: 4590632
    [No Abstract] [Full Text] [Related]

  • 4. The effect of Flavoxate R on neurogenic bladder dysfunction.
    Pedersen E, Bjarnason EV, Hansen PH.
    Acta Neurol Scand Suppl; 1972 Oct 22; 51():487-8. PubMed ID: 4514388
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of flavoxate on urinary bladder contraction, micturition reflex and urodynamic parameters.
    Pietra C, Cazzulani P.
    Farmaco Prat; 1986 Aug 22; 41(8):267-73. PubMed ID: 3743737
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urodynamic response of unstable bladder to flavoxate.
    Zanollo A, Catanzaro F.
    Urol Int; 1980 Aug 22; 35(3):176-81. PubMed ID: 7385465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability.
    Cardozo LD, Stanton SL.
    J Urol; 1979 Jul 22; 122(1):58-9. PubMed ID: 458990
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Gamé X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudié I, De Boissezon X, Malavaud B, Marque P, Rischmann P.
    Eur Urol; 2008 Mar 22; 53(3):613-8. PubMed ID: 17804150
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of flavoxate antispasmodic activity comparative in vitro studies.
    Cazzulani P, Panzarasa R, De Stefani C, Graziani G.
    Arch Int Pharmacodyn Ther; 1985 Apr 22; 274(2):189-200. PubMed ID: 4026456
    [Abstract] [Full Text] [Related]

  • 17. A comparison between the combination emepronium bromide/flavoxate and emepronium bromide in the treatment of detrusor instability.
    Aagaard J, Reuther K, Stimpel H.
    Urol Int; 1983 Apr 22; 38(3):191-2. PubMed ID: 6868218
    [Abstract] [Full Text] [Related]

  • 18. Bladder muscle contractility. Comparative effects and mechanisms of action of atropine, propantheline, flavoxate, and imipramine.
    Benson GS, Sarshik SA, Raezer DM, Wein AJ.
    Urology; 1977 Jan 22; 9(1):31-5. PubMed ID: 831350
    [Abstract] [Full Text] [Related]

  • 19. The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly.
    Briggs RS, Castleden CM, Asher MJ.
    J Urol; 1980 May 22; 123(5):665-6. PubMed ID: 7420551
    [Abstract] [Full Text] [Related]

  • 20. An urodynamic study of emepronium bromide in bladder dysfunction.
    Ekeland A, Sander S.
    Scand J Urol Nephrol; 1976 May 22; 10(3):195-9. PubMed ID: 1006180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.